Oral Ondansetron in the Prevention of Chemotherapy-induced Emesis in Breast Cancer Patients

By Clavel M.   Bonneterre J.   d'Allens H.   Paillarse J.-M.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite

Prevention of Delayed Emesis Induced by Moderately Emetogenic Chemotherapy in Patients with Acute Emesis: A Pilot Study with ACTH-Depot Plus Tropisetron

By Santini D.   Vincenzi B.   Fossati C.   D'Angelillo R.M.   Patti G.   Bianco V.   Avvisati G.   Tonini G.  

Medical Oncology, Vol. 18, Iss. 2, 2001-03 ,pp. : 131-135

Humana Press, Inc

Access to resources Recommend Favorite

Comparison of Granisetron Alone and Granisetron Plus Hydroxyzine Hydrochloride for Prophylactic Treatment of Emesis Induced by Cisplatin Chemotherapy

By Tsukuda M.   Furukawa S.   Kokatsu T.   Enomoto H.   Kubota A.   Furukawa M.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1647-1649

Elsevier

Access to resources Recommend Favorite

Ondansetron for the Control of Dacarbazine-induced Emesis

By Campora E.   Chiara S.   Aschele C.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1720-1721

Elsevier

Access to resources Recommend Favorite

The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial

By Yu Zhaocai  

Supportive Care in Cancer, Vol. 17, Iss. 1, 2009-01 ,pp. : 99-102

Springer Publishing Company

Access to resources Recommend Favorite